We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,605 results
  1. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis

    Background

    Chronic stress promotes most hallmarks of cancer through impacting the malignant tissues, their microenvironment, immunity, lymphatic flow,...

    Jun Pan, Leyi Zhang, ... Jian Huang in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 September 2023
  2. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy

    Introduction

    Conventional treatment of pulmonary metastatic sarcoma primarily involves surgery, with systemic therapy added in select patients....

    Paulina M. Gutkin, Elizabeth Gore, ... Meena Bedi in Radiation Oncology
    Article Open access 01 March 2023
  3. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization

    Purpose

    For patients with osteosarcoma, disease-related mortality most often results from lung metastasis—a phenomenon shared with many solid tumors....

    Camille A. McAloney, Rawan Makkawi, ... Ryan D. Roberts in Cellular Oncology
    Article Open access 07 September 2023
  4. Hypoxia and the Metastatic Cascade

    Metastasis is a leading cause of mortality in cancer patients. The journey of a detached primary tumour cell to a secondary homing site is a...
    Sanchit Gandhi, Shruti Khanna, ... Tapasya Srivastava in Hypoxia in Cancer: Significance and Impact on Cancer Therapy
    Chapter 2023
  5. A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

    Background

    Immunotherapy targeting the PD-1/PD-L1 pathway is a standard of care in a number of metastatic malignancies, but less than a fifth of...

    Nicolas Roussot, Jean-David Fumet, ... Céline Mirjolet in BMC Cancer
    Article Open access 09 November 2023
  6. Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data

    Background

    The impact of immune checkpoint inhibitors (ICIs) based treatments on non-small cell lung cancers (NSCLCs) with RET fusions remains poorly...

    Ningning Yan, Huixian Zhang, ... **ngya Li in BMC Cancer
    Article Open access 05 February 2024
  7. Synbiotics in Lung Cancer

    Human microbiota has gained significant interest in the prevention and treatment of cancer. Synbiotics are profound examples of how microbiota can be...
    Diwahar Prakash, Suresh Krishna Venkataramanan, ... Senthil Visaga Ambi in Synbiotics for the Management of Cancer
    Chapter 2023
  8. A Phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer

    Background

    Nivolumab with modified FOLFIRINOX (mFOLFIRINOX) may have additive antitumour effects while minimising chemotherapy cytotoxicity. We...

    Chigusa Morizane, Makoto Ueno, ... Junji Furuse in BJC Reports
    Article Open access 23 January 2024
  9. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer

    Metastasis occurs frequently after resection of pancreatic cancer (PaC). In this study, we hypothesized that multi-parametric analysis of...

    Linda Bojmar, Constantinos P. Zambirinis, ... David Lyden in Nature Medicine
    Article 28 June 2024
  10. Cancer treatments as paradoxical catalysts of tumor awakening in the lung

    Much of the fatality of tumors is linked to the growth of metastases, which can emerge months to years after apparently successful treatment of...

    Emmanuelle Nicolas, Beata Kosmider, ... Lucia Borriello in Cancer and Metastasis Reviews
    Article Open access 04 July 2024
  11. CTLA-4 Inhibitors for the Treatment of Lung Cancer

    One of the most prevalent malignancies and the main reason for cancer-related deaths globally is lung cancer. The majority of these non-small-cell...
    Shvetank Bhatt, Shreya Sharma, ... Rohini Pujari in Immunotherapy Against Lung Cancer
    Chapter 2024
  12. Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

    Background

    Standard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy,...

    Fernanda Costa Svedman, Karin Holmsten, ... Anders Ullén in Radiation Oncology
    Article Open access 16 June 2024
  13. PMS2 amplification contributes brain metastasis from lung cancer

    Background

    Lung adenocarcinoma metastasizing to the brain results in a notable increase in patient mortality. The high incidence and its impact on...

    Jianing Chen, Congli Hu, ... Chunxia Su in Biological Procedures Online
    Article Open access 07 May 2024
  14. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

    Adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) has shown activity in melanoma, but has not been previously evaluated in metastatic...

    Benjamin C. Creelan, Chao Wang, ... Scott J. Antonia in Nature Medicine
    Article 12 August 2021
  15. Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skip** mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study

    Background

    As a potential target receptor tyrosine kinase, mesenchymal-epithelial transition factor ( MET ) exhibits high aberrant expression across...

    **ngsheng Hu, **nge Cui, ... Yuankai Shi in BMC Cancer
    Article Open access 11 April 2023
  16. Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential

    Background

    Metastasis is the leading cause of death in breast cancer patients. For metastasis to occur, tumor cells must invade locally, intravasate,...

    Sydney J. Conner, Justinne R. Guarin, ... Madeleine J. Oudin in Breast Cancer Research
    Article Open access 11 March 2024
  17. The incorporation of acetylated LAP-TGF-β1 proteins into exosomes promotes TNBC cell dissemination in lung micro-metastasis

    Triple-negative breast cancer (TNBC) stands as the breast cancer subtype with the highest recurrence and mortality rates, with the lungs being the...

    Pei Yu, Yubao Han, ... Lingyi Kong in Molecular Cancer
    Article Open access 25 April 2024
  18. How much do we know about the metastatic process?

    Cancer cells can leave their primary sites and travel through the circulation to distant sites, where they lodge as disseminated cancer cells (DCCs),...

    Carolina Rodriguez-Tirado, Maria Soledad Sosa in Clinical & Experimental Metastasis
    Article Open access 23 March 2024
  19. Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study

    Background

    Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high...

    Emmanuel Mesny, Myriam Ayadi, ... Isabelle Martel-Lafay in Radiation Oncology
    Article Open access 22 February 2023
Did you find what you were looking for? Share feedback.